Related references
Note: Only part of the references are listed.Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer
M Luukkaa et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2006)
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma
J Nikkola et al.
CLINICAL CANCER RESEARCH (2005)
Matrix metalloproteinases as therapeutic targets in cancer
P Vihinen et al.
CURRENT CANCER DRUG TARGETS (2005)
β-6 integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms
TH Westernoff et al.
ORAL ONCOLOGY (2005)
Salivary gland cancer in Finland 1991-96:: An evaluation of 237 cases
H Luukkaa et al.
ACTA OTO-LARYNGOLOGICA (2005)
Laminin-1 and SIKVAV a laminin-1-derived peptide, regulate the morphology and protease activity of a human salivary gland adenoid cystic carcinoma cell line
VM Freitas et al.
ORAL ONCOLOGY (2004)
Activation of pro-MMP-2 mediated by MTI-MMP in human salivary gland carcinomas: Possible regulation of pro-MMP-2 activation by TIMP-2
K Kayano et al.
JOURNAL OF PATHOLOGY (2004)
Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1,-2, and-3 in benign and malignant tumours of the salivary gland
H Nagel et al.
HISTOPATHOLOGY (2004)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops
P O-Charoenrat et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma
J Nikkola et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
